In the news

EKF launches POC hemoglobin analyzer at Medica 2014 27^th Oct 2014	EKF to attend CMEF 2014 14^th Oct 2014
EKF Diagnostics 2014 International Distributor Meeting 1^st Oct 2014	US collaboration to develop blood tests for cancer 23^rd Sep 2014
Blood Drive at EKF-diagnostic GmbH 11^th Sep 2014	EKF-diagnostic GmbH part of new medical engineering network 10^th Sep 2014
Webinar: A Novel Method of Studying DNA Damage 27^th Aug 2014	EKF Diagnostics Growing Product Portfolio Highlighted at AACC 2014 23^rd Jul 2014
New data using EKF PointMan™ 21^st Jul 2014	Contract win and regulatory approval 8^th Jul 2014
Stanbio Life Sciences re-branded 1^st Jul 2014	EKF collaborator to deliver Kelly West Lecture at ADA 9^th Jun 2014
EKF Molecular Diagnostics and GILUPI announce CTC DNA enrichment success 29^th May 2014	Studies validate early stage test for progressive Diabetic Kidney Disease 22^nd May 2014
Selah to provide testing services for Women's Health 20^th May 2014	EKF Diagnostics launches Premium Partnership Program 6^th May 2014
New Lactate Scout+ analyzer launched 16^th Apr 2014	EKF announces acquisition of Separation Technology, Inc. 27^th Mar 2014
EKF highlights ultra-sensitive cancer mutation detection kits at AACR 24^th Mar 2014	Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB 20^th Mar 2014
PointMan at Tri-Con 2014 10^th Feb 2014	PointMan™ successfully enriches low-level mutations in DNA extracted from blood 20^th Jan 2014
EKF Diagnostics' Quo-Lab HbA1c analyzer secures IFCC Certification 8^th Jan 2014	EKF Diagnostics exhibits new POC testing technology at Arab Health 7^th Jan 2014

Reset

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF Diagnostics launches Premium Partnership Program

EKF Diagnostics announces the introduction of a Premium Partnership Program and the appointment of Simona Carnielli as EMEA Distribution Manager .

New Lactate Scout+ analyzer launched

Lactate testing with hematocrit compensation is ideal for sports medical health checks.

EKF announces acquisition of Separation Technology, Inc.

This acquisition complements EKF’s existing offering in the hemoglobin testing market place, which includes Hemo Control (also sold as HemoPoint H2 in USA and Asia).

EKF highlights ultra-sensitive cancer mutation detection kits at AACR

PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB

EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers.